Cellebrite DI share price logo

Cellebrite DI

NASDAQ: CLBT

Mid Cap

$12.69

+0.03

(+0.20%)

as on

Cellebrite DI Stock Performance

as on April 29, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $12.51
    $12.95
    downward going graph

    1.42%

    Downside

    2.05%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $11.02
    $20.53
    downward going graph

    13.16%

    Downside

    61.78%

    Upside

    downward going graph

Cellebrite DI share price movements today

Previous Close
$12.66
Open
$12.78
Volume
1.7M
Day's Low - High
$12.51 - $12.95
52 Week Low - High
$11.02 - $20.53

Cellebrite DI Historical Returns

1 Month Return
-2.08 %
3 Month Return
-17.07 %
1 Year Return
-36.92 %
3 Year Return
+ 134.38 %
5 Year Return
0 %

Cellebrite DI Stock Fundamentals & Key Indicators

Check Cellebrite DI market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.2B

EPS (TTM)

0.5303

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.02%

PE Ratio (TTM)

40.84

Industry PE ratio

22.647666666666666

PEG Ratio

0

EBITDA

78.3M

Revenue (TTM)

475.7M

Profit Margin

16.47%

Return On Equity TTM

19.10%

Cellebrite DI Stock Valuation

Track how Cellebrite DI P/E has moved over time to understand its valuation trends.

Cellebrite DI in the last 5 years

  • Overview

  • Trends

Lowest (16.54x)

December 31, 2022

Industry (22.65x)

April 29, 2026

Today (40.84x)

April 29, 2026

Highest (70.28x)

September 30, 2021

LowHigh

Today’s Price to Earnings Ratio: 40.84x

Cellebrite DI vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cellebrite DI with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$3.2BNA40.8416.47%
HOLD$343.0B504.11%227.1436.31%
BUY$115.4B115.09%NA-3.38%
BUY$146.8B205.77%101.1112.96%
BUY$477.3B118.74%29.7425.30%

Stock Returns calculator for Cellebrite DI Stock including INR - Dollar returns

The Cellebrite DI stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Cellebrite DI investment value today

Current value as on today

₹70,294

Returns

-₹29,706

(-29.71%)

Returns from Cellebrite DI Stock

-₹36,866 (-36.87%)

Dollar Impact

₹7,159 (+7.16%)

Analyst Recommendation on Cellebrite DI Stock

Based on 14 analysts

BUY

92.86%

Buy

7.14%

Hold

0.00%

Sell

Based on 14 analysts, 92.86% of analysts recommend a 'BUY' rating for Cellebrite DI. Average target price of $21.67

Cellebrite DI Share Price Target

Get share price movements and forecasts by analysts on Cellebrite DI.

What analysts predicted

41.44%UPSIDE

Target Price

$21.67

Current Price

$12.69

Analyzed by

14 Analysts

Target

$21.67

Cellebrite DI target price $21.67, a slight upside of 41.44% compared to current price of $12.69. According to 14 analysts rating.

Cellebrite DI Stock’s Investor Sentiment and Interest

Search interest for Cellebrite DI Stock has increased by 33% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:33% versus previous 30 day period

Cellebrite DI Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
84
93
89
95
106
109
107
113
126
128
Gross Profit
71
78
76
79
91
91
90
95
105
109
Operating Income
13
14
9
12
19
15
12
14
18
20
EBITDA
15
17
11
15
22
18
14
17
26
24
Interest Expense
6
78
78
34
223
1
-
-
-
-
Depreciation
2
2
2
2
2
2
2
2
2
3
Income Before Tax
6
-12
-69
-22
-204
19
19
20
24
26
Income Tax Expense
0
2
2
1
2
0
1
1
4
5
Net Income
6
-14
-71
-23
-207
19
17
19
20
21
Net Profit Margin
7.72%
-15.75%
-79.67%
-24.88%
-193.80%
17.67%
16.18%
17.19%
16.02%
16.50%

Cellebrite DI Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
171
194
246
270
325
401
475
Gross Profit
136
157
203
219
271
338
400
Operating Income
-1
9
13
1
33
56
66
EBITDA
5
17
89
130
-64
67
78
Interest Expense
0
1
0
0
0
349
0
Depreciation
4
5
7
9
9
10
11
Income Before Tax
1
11
82
120
-75
-275
90
Income Tax Expense
3
5
10
0
5
7
12
Net Income
-1
5
71
120
-81
-283
78
Net Profit Margin
-1.09%
2.97%
28.99%
44.63%
-24.95%
-70.54%
16.47%

Cellebrite DI Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-14
-71
-23
-207
19
17
19
20
21
Operating Cash Flow
43
10
14
41
65
20
32
33
82
Investing Cash Flow
3
-81
-33
-18
-15
-126
40
63
-246
Financing Cash Flow
4
5
3
5
6
3
13
5
6
Change in Cash
52
-67
-15
29
55
-101
88
102
-156

Cellebrite DI Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
5
71
120
-81
-283
78
Operating Cash Flow
66
36
20
102
132
168
Investing Cash Flow
-6
45
-91
-22
-149
-268
Financing Cash Flow
-8
-68
13
21
20
29
Change in Cash
52
12
-58
101
2
-67

Global Institutional Holdings in Cellebrite DI

Funds
Holdings
Clal Insurance Enterprises Holdings Ltd
1.39%
Nuveen, LLC
0.91%
Principal Financial Group Inc
0.66%
Handelsbanken Fonder AB
1%
Cooper Creek Partners Management LLC
0.96%

Cellebrite DI News & Key Events

  • img

    Today's Timeline - 13 November

    Thu, 05:52 PM

    -

    Bank of America reiterates Buy rating on Cellebrite, highlighting recovery in Federal demand and growth potential.

    Thu, 08:52 PM

    -

    William Blair maintains Buy rating on CLBT, citing strong financial performance and promising growth prospects.

    Thu, 10:48 PM

    -

    Cellebrite stock climbs 23% after earnings beat expectations, with revenue and adjusted EBITDA also exceeding forecasts.

  • img

    Today's Timeline - 13 November

    Thu, 11:51 PM

    -

    Cellebrite reports strong Q3 results, raising full-year sales and ARR targets, boosting investor confidence.

Insights on Cellebrite DI

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 107.54M → 128.82M (in $), with an average increase of 5.8% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, 17.4M → 21.26M (in $), with an average increase of 6.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Palantir Technologies Inc has given 1721.7% return, outperforming this stock by 1587.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Palantir Technologies Inc has given 21.6% return, outperforming this stock by 58.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, CLBT stock has moved down by -2.1%

About Cellebrite DI

Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency. It also offers Inseyets, digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations; Guardian Forensics, an evidence management solution which enables customers to manage their digital forensics workflows, and to store, share and review digital evidence; Guardian Collaborate, a digital evidence sharing tool; and Guardian Investigate, a case management and AI-powered analytics solution. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence and enables actionable insights into a range of crime types; Corellium Falcon for conducting mobile vulnerability research, exploit introspection, and malware analysis; and Corellium Viper for mobile application penetration testing capabilities. Further, the company offers professional services, such as training and certification services, and advanced services. It serves federal, state, and local agencies, as well as corporations and service providers. The company is headquartered in Petah Tikva, Israel.
OrganisationCellebrite DI
Headquarters94 Shlomo Shmelzer Road, Petah Tikva, Israel, 4970602
IndustrySoftware - Infrastructure
CEOMr. Thomas E. Hogan
E-voting on sharesClick here to vote

Key Management of Cellebrite DI

Name

Title

Mr. David Barter

Chief Financial Officer

Mr. Marcus Jewell

Global Chief Revenue Officer

Mr. Christopher Wade

Chief Technology Officer

Andrew Kramer

Vice President of Investor Relations

Ms. Holly B. Windham Esq., J.D.

General Counsel & Chief Compliance Officer

Mr. Thomas E. Hogan

CEO & Director

Mr. Ronnen Armon

Chief Products & Technologies Officer

Ms. Sigalit Shavit

Chief Information Officer

Mr. David Nicholas Gee

Chief Marketing Officer

Ms. Zohar Tadmor-Eilat

Chief People Officer

FAQs

What is Cellebrite DI share price today?

Cellebrite DI share price today is $12.69 as on at the close of the market. Cellebrite DI share today touched a day high of $12.95 and a low of $12.51.

What is the 52 week high and 52 week low for Cellebrite DI share?

Cellebrite DI share touched a 52 week high of $20.53 on and a 52 week low of $11.02 on . Cellebrite DI stock price today i.e. is closed at $12.69,which is 38.19% down from its 52 week high and 15.15% up from its 52 week low.

What is Cellebrite DI's market capitalisation today?

Cellebrite DI market capitalisation is $0.00T as on .

How to invest in Cellebrite DI Stock (CLBT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cellebrite DI on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cellebrite DI Shares that will get you 0.1182 shares as per Cellebrite DI share price of $12.69 per share as on April 29, 2026 at 1:29 am IST.

What is the minimum amount required to buy Cellebrite DI Stock (CLBT) from India?

Indian investors can start investing in Cellebrite DI (CLBT) shares with as little as ₹94.82 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹948.20 in Cellebrite DI stock (as per the Rupee-Dollar exchange rate as on ). Based on Cellebrite DI share’s latest price of $12.69 as on April 29, 2026 at 1:29 am IST, you will get 0.7880 shares of Cellebrite DI. Learn more about fractional shares .